Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

68 results about "Streptococcus zooepidemicus" patented technology

Streptococcus zooepidemicus is a Lancefield group C streptococcus that was first isolated in 1934 by P. R. Edwards, and named Animal pyogens A. It’s a mucosal commensal and opportunistic pathogen that infects several animals and humans, but most commonly isolated from the uterus of Mares. It’s a subspecies of Streptococcus equi, a contagious upper respiratory tract infection of horses, and shares greater than 98% DNA homology, as well as many of the same virulence factors.

Hyaluronidase expression vector and application thereof

The invention relates to an expression plasmid containing streptococcus zooepidemicus hyaluronidase genes and the application thereof and aims at providing a streptococcus zooepidemicus hyaluronidase expression vector, a recombinant Escherichia coil cell, a method for generating the hyaluronidase by using the cell and a method for preparing a hyaluronic acid oligose. By using a PCR method, the expression plasmid containing coding genes of the streptococcus zooepidemicus hyaluronidase is formed; a recombinant Escherichia coil strain is obtained by transforming the expression plasmid; and the hyaluronidase is generated by expressing the engineering bacterium. The hyaluronidase expression vector is an Escherichia coil expression vector containing streptococcus zooepidemicus hyaluronidase genes. The method for expressing the zooepidemicus hyaluronidase comprises the following steps of: culturing the recombinant Escherichia coil cells; expressing the hyaluronidase by controlling the temperature or IPTG induction; and using the hyaluronidase to prepare the HA oligose. The method for preparing the hyaluronidase has the characteristics of high expression level, easily expanded production and low cost. The hyaluronidase of the invention can be applied to degrading a hyaluronic acid.
Owner:INST OF BIOPHARM OF SHANDONG PROVINCE

Production method for extracting and purifying hyaluronic acid

The invention discloses a production method for extracting and purifying hyaluronic acid, for solving the problems such as long process route, long production period, high labor intensity, more human factors influencing product quality and relatively low product yield, existing in the purification of the traditional CPC (Cetyl Pyridinium Chloride) complexing ethanol sedimentation technology. The production method comprises the following steps of: fermentation liquor inactivation, primary alcohol precipitation, rough separation, redissolution, primary filtering decontamination, secondary filtering purification, alcohol precipitation crystallization, drying and smashing. The invention provides an industrial extraction and purification method of fermentation liquor for producing the hyaluronic acid through a streptococcus zooepidemicus fermentation method. The industrial extraction and purification method provided by the invention has the characteristics of short process route and production period, high adaptability, low production cost and good effect, can be concluded into a secondary filtering and secondary alcohol precipitation extraction process and is proved to be feasible through a small-scale test and a pilot scale test in a laboratory and verification in actual production and can meet the requirement for industrialized production.
Owner:SICHUAN HENGYI TECH

Method for preparing mask base materials

The invention provides a method for preparing mask base materials. The method includes steps of acquiring coconut water, adding xylan and pectin into the coconut water, carrying out pasteurization, then inoculating acetobacter xylinum into the coconut water, cultivating the acetobacter xylinum until fibrous membranes with the thicknesses of 0.1-0.5 cm are formed on the surface of fermentation liquor, adding cellulase into the fibrous membranes, treating the fibrous membranes, then carrying out ultrasonic treatment on the fibrous membranes in sodium hydroxide solution, washing the fibrous membranes by the aid of clear water until the fibrous membranes are neutral, slicing the fibrous membranes and then carrying out freeze drying on the fibrous membranes to obtain cellulose substrates; acquiring streptococcus zooepidemicus fermentation liquor containing hyaluronic acid, centrifugally removing precipitates, adding supernate into albumen powder, uniformly mixing the supernate and the albumen powder with each other to obtain mixtures, then adding the cellulose substrates into the mixtures, carrying out ultrasonic treatment, taking out the cellulose substrates after ultrasonic treatment is completely carried out, thorough flushing the mixtures by the aid of clear water, carrying out freeze drying on the mixtures and then packaging the mixtures under vacuum conditions to obtain the mask base materials. The method has the advantages that the mask base materials prepared by the aid of the method are excellent in human skin compatibility, free of skin irritation and suitable for various skin types; the mask base materials contain abundant hyaluronic acid, the hyaluronic acid is uniformly distributed, excellent slow-release effects can be realized, the mask base materials are long in skin retention time and are nutritional, and moisture can be preserved.
Owner:陈雄

Method for breeding fermentation high stability hyaluronic acid sodium bacterial

The invention discloses a method for culturing a high-stability sodium hyaluronate strain, which comprises the step of adoption of streptococcus zooepidemicus with a number of ATCC39920. The method is characterized in that the streptococcus zooepidemicus with the number of ATCC39920 is subjected to strain culture and fermentation culture; after repeating the steps and performing repeated tests for 200 times, a strain for fermentation is obtained; fermentation culture of sodium hyaluronate is performed in a fermentation medium; and the fermentation medium is subjected to slight sterilization for 20 minutes at the temperature of 121 DEG C, cooled and cultured at a temperature of between 36 and 37 DEG C and at a pH value of between 6.8 and 7.1, enters the after-treatment step after culturing the sodium hyaluronate for 30 hours without limiting the air flow, and the high-stability sodium hyaluronate is obtained. Under the same conditions, the prior strain which is not subjected to optimization treatment is used for fermentation and production of the sodium hyaluronate; and the stability of the sodium hyaluronate finished product is obviously higher than that of an external sodium hyaluronate sample by comparing and examining the stability of the two types of sodium hyaluronate.
Owner:TONGXIANG HENGJI BIOTECH

Preparation method and application of small molecular weight hyaluronic acid, and hyaluronate lyase genetic vector and engineering bacteria

The invention provides a preparation method and application of small molecular weight hyaluronic acid, and a hyaluronate lyase genetic vector and engineering bacteria. An expression vector successfully constructed is converted to Escherichia coli BL21 (DE3) by: cloning part of fragments encoding hyaluronate lyase gene (hylb) in genome of Streptococcus zooepidemicus ATCC 39920 and constructing the expression carrier pET 28a:hylb, and high-activity soluble hyaluronate lyase is obtained by the induced expression of Escherichia coli. Specific enzyme activity of purified liquid of the lyase is 4655 U/mg (equivalently 4.655*107 IU/mg) that is measured by N-acetyl-glucosamine (NAG) measurement. The small molecular weight hyaluronic acid is prepared by controlling the enzyme content and reaction conditions to degrade large molecular weight hyaluronic acid, the molecular weight of the hyaluronic acid is measured by means of an intrinsic viscosity method and agarose gel electrophoresis, and the obtained molecular weight is that of small molecular weight hyaluronic acid of 6000Da level, an infrared spectrogram of which is consistent with standard atlas in national pharmacopoeia.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

A microbial fermentation process amplification platform technology

The invention provides a microorganism fermentation process scaling-up platform technique. In the process of fermentation, symbolic metabolites are chosen to reflect the growing state of microorganisms and the condition of fermentation medium, and by controlling the change of the symbolic metabolites, and combined with hydromechanics to calculate, design and improve the size and structure of a stirring reactor, the gas holdup is increased and the concentration of the symbolic metabolites is decreased; and fermentation conditions are optimized and the fermentation process is scaled up. The technique is applied in the production of glutathione and S-adenosine-L-methionine and the coproduction of glutathione and ergosterol by brewing yeast fermentation and the production of hyaluronic acid by streptococcus zooepidemicus fermentation. The symbolic metabolites are ethanol, glycerin, lactic acid and acetic acid. The technique ensures that the concentration of ethanol in the high-density aerobic fermentation of yeast is less than 0.5 percent and that the concentration of lactic acid as the symbolic metabolite in the production of hyaluronic acid by bacterial fermentation is less than 3 percent. The technique is easy to operate, and the automation degree is high; and the application range is wide, and the technique can be used in the yeast system as well as the bacteria system.
Owner:BEIJING UNIV OF CHEM TECH

Streptococcus equi strain XJMSY16-1 and application thereof in streptococcus equi vaccine

The invention relates to Streptococcus equi (also named as Streptococcus equi subsp.zooepidemicus) XJMSY16-1 with the preservation number of CGMCC No.12428. The strain has 16S rRNA gene sequences in asequence table 1. The stain is separated from sick horses suffering from Streptococcus equi and is a positive Gram bacterium, cells of the strain take the shapes of spheres and are arranged in pairs,or take the shapes of bent long chains, and are low in growth property in common meat soup and panels; beta-type hemolysis is caused on a panel with 5% fresh sheep blood, completely transparent hemolysis zones are formed around small dewdrop shaped bacterial colonies, and the width of the hemolysis zones can be up to 2.5-3.2 mm. The strain grows in a facultative anaerobic manner, the growth temperature is 26-40 DEG C, the most appropriate temperature is 37 DEG C, and the most appropriate growth pH value is 7.4-7.5. Glucose can be fermented to generate acids, and lactose, mannitol and sorbitolcannot be fermented with the strain. The strain can be used for preparing streptococcus equi deactivation vaccines. The vaccines prepared from the strain are high in disease specificity, low in cost,high in security and good in protection effect.
Owner:XINJIANG AGRI UNIV

Material supplement method for hyaluronic acid fermentation

The invention discloses a material supplement method for hyaluronic acid fermentation. The method comprises the steps that streptococcus zooepidemicus is inoculated to a culture medium of slope bacterial strains, and activated streptococcus zooepidemicus bacterial strains are obtained; an appropriate amount of glucose, yeast powder, peptone, dipotassium phosphate and magnesium sulfate are taken, poured into a seed culture medium for mixing and then sterilized; the activated streptococcus zooepidemicus bacterial strains are inoculated to the seed culture medium to obtain a seed solution, and the seed solution is inoculated to an amplification culture medium for amplification culture to obtain an amplification culture solution. The material supplement method for hyaluronic acid fermentationhas the advantages that the materials are conveyed into a fermentation tank for inoculated fermentation through a batch or continuous material supplement mode, the concentration of Ca and Mg ions in afermentation solution is increased, the reaction among all components of the fermentation solution in the preparation process at the early period is reduced, damage to nutrient components is reduced,the utilization rate of the nutrient components is increased, fermentation is facilitated, the fermentation viscosity reaches 63,750 mPa*s, and the method helps to improve the fermentation quality and increase the fermentation yield.
Owner:SHANDONG FOCUSFREDA BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products